What are the causes of spontaneous pneumothorax?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Spontaneous pneumothorax is primarily caused by the rupture of subpleural blebs and bullae, which are found in up to 90% of cases of primary pneumothorax, with smoking being a significant risk factor. The exact aetiology of these bullous changes in otherwise healthy lungs is unclear, but smoking plays a crucial role, with a lifetime risk of developing a pneumothorax in healthy smoking men being as much as 12% compared to 0.1% in non-smoking men 1. Primary spontaneous pneumothorax typically occurs in people without underlying lung disease, whereas secondary spontaneous pneumothorax develops in patients with pre-existing lung conditions. Some key points to consider include:

  • The incidence of primary pneumothorax is reported to be 18–28/100 000 per year for men and 1.2–6/100 000 per year for women 1
  • Hospital admission rates for combined primary and secondary pneumothorax are reported in the UK at between 5.8/100 000 per year for women and 16.7/100 000 per year for men 1
  • Mortality rates in the UK were 0.62/million per year for women and 1.26/million per year for men between 1991 and 1995 1
  • Smoking cessation is essential in preventing the recurrence of pneumothorax, as emphasized by the strong relationship between smoking and the development of pneumothorax 1.

From the Research

Causes of Spontaneous Pneumothorax

The causes of spontaneous pneumothorax can be divided into two main categories: primary and secondary.

  • Primary spontaneous pneumothorax (PSP) is not associated with any underlying lung disease, but is thought to be caused by diffuse and often bilateral abnormalities within the pleura, including emphysema-like changes, pleural porosity, and inflammation 2.
  • Secondary spontaneous pneumothorax (SSP) is associated with underlying lung diseases, such as:
    • Cystic fibrosis 3
    • Chronic obstructive pulmonary disease (COPD) 3, 4
    • Interstitial lung disease (ILD) 3

Underlying Pathological Processes

The underlying pathological processes that contribute to spontaneous pneumothorax include:

  • Rupture of subpleural blebs/bullae in the underlying lung 5
  • Emphysema-like changes in the pleura 2
  • Pleural porosity and inflammation 2 These processes can lead to the accumulation of air in the pleural cavity, resulting in a spontaneous pneumothorax.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Primary spontaneous pneumothorax: a diffuse disease of the pleura.

Respiration; international review of thoracic diseases, 2012

Research

Current management of spontaneous pneumothorax.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2005

Related Questions

What is the management of secondary spontaneous pneumothorax according to British Thoracic Society (BTS) guidelines?
Does an asymptomatic spontaneous pneumothorax (collapsed lung) require supplemental oxygen (O2)?
When to consult cardiothoracic surgery for a patient with bullous lung disease and first spontaneous pneumothorax with incomplete lung expansion after 5 days of chest drainage?
Can a pneumothorax (collapsed lung) cause air to enter the abdomen?
What is the appropriate aftercare for spontaneous pneumothorax in young males?
What is the next step for a patient on Cellcept (Mycophenolate Mofetil), Rituximab, high-dose Intravenous Immunoglobulin (IVIG), Prednisone, and Plaquenil (Hydroxychloroquine) with persistent active inflammation, neutrophilia, and hypocomplementemia?
What are the next steps for a patient on Actemra (Tocilizumab), Cellcept (Mycophenolate Mofetil), intravenous (IV) Rituximab, high-dose intravenous immunoglobulin (IVIG), Prednisone, and Plaquenil (Hydroxychloroquine) with persistent active inflammation, neutrophilia, hypocomplementemia, and synovitis, despite previous failure of Methotrexate (MTX)?
What is the diagnosis and treatment for spontaneous pneumothorax?
What are the implications of a pseudocyst (false cyst) in a patient with a pancreatic transplant?
What are the next steps for a patient with active inflammation, elevated neutrophils, and low complement levels, despite treatment with Actemra (Tocilizumab), Cellcept (Mycophenolate mofetil), intravenous Rituximab, high-dose intravenous Immunoglobulin (IVIG), Prednisone, and Plaquenil (Hydroxychloroquine), with persistent synovitis and previous failure of Methotrexate (MTX) and combination therapy with Xeljanz (Tofacitinib) and Leflunomide?
What is the relationship between spontaneous pneumothorax and Coronavirus Disease (COVID-19)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.